Last reviewed · How we verify
American Ginseng root — Competitive Intelligence Brief
marketed
Herbal supplement / Adaptogen
Immunology / General wellness
Small molecule
Live · refreshed every 30 min
Target snapshot
American Ginseng root (American Ginseng root) — Southern Illinois University. American Ginseng root contains bioactive compounds (ginsenosides) that modulate immune function, reduce inflammation, and enhance stress resilience through multiple signaling pathways.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| American Ginseng root TARGET | American Ginseng root | Southern Illinois University | marketed | Herbal supplement / Adaptogen | ||
| KRG (Korea Red ginseng) | KRG (Korea Red ginseng) | Chuncheon Sacred Heart Hospital | marketed | Herbal supplement / adaptogen |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Herbal supplement / Adaptogen class)
- Southern Illinois University · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- American Ginseng root CI watch — RSS
- American Ginseng root CI watch — Atom
- American Ginseng root CI watch — JSON
- American Ginseng root alone — RSS
- Whole Herbal supplement / Adaptogen class — RSS
Cite this brief
Drug Landscape (2026). American Ginseng root — Competitive Intelligence Brief. https://druglandscape.com/ci/american-ginseng-root. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing